Landscapes / Targets
NMDAR NR1
1 drug acts on NMDAR NR1, in 1 active trial · Any stage · updated 20 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Nov 2027Phase 2 trial completes | |||
| Next date | 30 Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · openFDA updated 20 Nov 2026